MediciNova (MNOV) Reports Q2 Loss, Tops Revenue Estimates

Impact · against what's priced in

MediciNova shows signs of improving fiscal health with a significant revenue beat and a narrower-than-expected loss. While the absolute figures remain small, the growth in quarterly revenue from $0.14 million to $0.46 million provides a positive update on the company's financial trajectory.

MNOV+0.40

No priced-in read yet

In context

The company reported quarterly revenue of $0.46 million, exceeding estimates by 205.63% and growing from $0.14 million a year ago, while narrowing its loss to $0.05 per share.

Read from the article alone

• earnings
• healthcare
• MNOV
• biopharma
• biotechnology
• earnings surprise
• revenue

Search tags